LENZ Therapeutics (LENZ)

• Market cap: $367M
• 1 day: -3.37%
• 5 days: -6.68%
• 1 month: -9.97%
• 3 months: -29.7%
• 6 months: -71.57%
• Year to date: -26.63%
• 1 year: -50.23%
• 5 years: -90.93%
• 10 years: -90.93%
• Sector: Healthcare
• Industry: Biotechnology

About: LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Employees: 42